sertindole has been researched along with Basal Ganglia Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christodoulou, C; Douzenis, A; Ferentinos, P; Lykouras, L; Papadopoulou, A; Peppa, M; Rizos, E | 1 |
| Perquin, L; Steinert, T | 1 |
| Perquin, LN | 1 |
| Casey, DE | 1 |
| Busatto, GF; Costa, DC; Davies, N; Ell, PJ; Kerwin, RW; Murray, RM; O'Connell, P; Pilowsky, LS | 1 |
| Daniel, DG; Kane, JM; Kashkin, KB; Mack, RJ; Sebree, TB; Tamminga, CA; Wallin, BA; Wozniak, PJ; Zimbroff, DL | 1 |
| Farde, L; Halldin, C; Mack, RJ; Nyberg, S | 1 |
| Brown, GR; Radford, JM | 1 |
| Hale, AS | 1 |
| Kasper, S | 1 |
| Abraham, D; Kissling, W; Leucht, S; Pitschel-Walz, G | 1 |
| Perregaard, J; Skarsfeldt, T | 1 |
5 review(s) available for sertindole and Basal Ganglia Diseases
| Article | Year |
|---|---|
A review of the efficacy, tolerability and safety of sertindole in clinical trials.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Cardiovascular Diseases; Clinical Trials as Topic; Cognition; Drug Tolerance; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Suicide; Treatment Outcome | 2004 |
Side effect profiles of new antipsychotic agents.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia; Seizures; Sleep; Weight Gain | 1996 |
A review of the safety and tolerability of sertindole.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Humans; Imidazoles; Indoles; Long QT Syndrome; Neurologic Examination; Risk Factors; Schizophrenia | 1998 |
How much do novel antipsychotics benefit the patients?
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Depression; Dose-Response Relationship, Drug; Humans; Imidazoles; Indoles; Male; Product Surveillance, Postmarketing; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Treatment Refusal | 1998 |
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 1999 |
4 trial(s) available for sertindole and Basal Ganglia Diseases
| Article | Year |
|---|---|
In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole--a 123I IBZM single photon emission tomography (SPET) study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Image Processing, Computer-Assisted; Imidazoles; Indoles; Iodine Radioisotopes; Male; Neostriatum; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon | 1997 |
Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitalization; Humans; Imidazoles; Indoles; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Treatment Outcome | 1997 |
D2 occupancy, extrapyramidal side effects and antipsychotic drug treatment: a pilot study with sertindole in healthy subjects.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Humans; Imidazoles; Indoles; Injections, Intravenous; Male; Pilot Projects; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed | 1997 |
Sertindole hydrochloride: a novel antipsychotic medication with a favorable side effect profile.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Electrocardiography; Humans; Imidazoles; Indoles; Male; Middle Aged; Schizophrenia | 1997 |
4 other study(ies) available for sertindole and Basal Ganglia Diseases
| Article | Year |
|---|---|
Androgen insensitivity and liability to drug-induced extrapyramidal symptoms.
Topics: Adult; Androgen-Insensitivity Syndrome; Antipsychotic Agents; Basal Ganglia Diseases; Chromosomes, Human, X; Disorder of Sex Development, 46,XY; Dopamine Antagonists; Female; Humans; Imidazoles; Indoles; Male; Mutation; Phenotype; Risk Assessment; Risk Factors; Risperidone | 2011 |
Treatment with the new antipsychotic sertindole for late-occurring undesirable movement effects.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Clopenthixol; Female; Haloperidol; Humans; Imidazoles; Indoles; Male; Middle Aged; Schizophrenia; Time Factors | 2005 |
The scourge of EPS: have atypical antipsychotics solved the problem?
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dibenzothiazepines; Dose-Response Relationship, Drug; Humans; Imidazoles; Indoles; Movement Disorders; Psychotic Disorders; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine; Receptors, Serotonin; Schizophrenia; Treatment Outcome | 2000 |
Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Dopamine; Dose-Response Relationship, Drug; Imidazoles; Indoles; Male; Neurons; Rats; Rats, Inbred Strains | 1990 |